CoChat

Integrated Isogenic Human Induced Pluripotent Stem Cell–Based Liver and Heart Microphysiological Systems Predict Unsafe Drug–Drug Interaction

Open access
Lee-Montiel, Felipe T., Laemmle, Alexander, Charwat, Verena, Dumont, Laure, Lee, Caleb S., Huebsch, Nathaniel, Okochi, Hideaki, Hancock, Matthew J., Siemons, Brian, Boggess, Steven C., Goswami, Ishan, Miller, Evan W., Willenbring, Holger, Healy, Kevin E. · 2021 · Frontiers in Pharmacology
Cited by 54

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

Three-dimensional (3D) microphysiological systems (MPSs) mimicking human organ function in vitro are an emerging alternative to conventional monolayer cell culture and animal models for drug development. Human induced pluripotent stem cells (hiPSCs) have the potential to capture the diversity of human genetics and provide an unlimited supply of cells. Combining hiPSCs with microfluidics technology in MPSs offers new perspectives for drug development. Here, the integration of a newly developed liver MPS with a cardiac MPS—both created with the same hiPSC line—to study drug–drug interaction (DDI) is reported. As a prominent example of clinically relevant DDI, the interaction of the arrhythmogenic gastroprokinetic cisapride with the fungicide ketoconazole was investigated. As seen in patients, metabolic conversion of cisapride to non-arrhythmogenic norcisapride in the liver MPS by the cytochrome P450 enzyme CYP3A4 was inhibited by ketoconazole, leading to arrhythmia in the cardiac MPS. These results establish integration of hiPSC-based liver and cardiac MPSs to facilitate screening for DDI, and thus drug efficacy and toxicity, isogenic in the same genetic background.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fphar.2021.667010

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Research works printed but not linked: 98

  1. Abboud, 2007, Drug-Induced Liver Injury, Drug Saf., 30, 277, 10.2165/00002018-200730040-00001 · DOI · Paper page
  2. Abhyankar, 2006, Characterization of a Membrane-Based Gradient Generator for Use in Cell-Signaling Studies, Lab. Chip, 6, 389, 10.1039/b514133h · DOI · Paper page
  3. Albert, 2007, Rat Liver Sinusoidal Endothelial Cells Survive without Exogenous VEGF in 3D Perfused Co-cultures with Hepatocytes, FASEB J., 21, 2564, 10.1096/fj.06-7473com · DOI · Paper page
  4. Allen, 2003, Formation of Steady-State Oxygen Gradients In Vitro: Application to Liver Zonation, Biotechnol. Bioeng., 82, 253, 10.1002/bit.10569 · DOI · Paper page
  5. Ardalani, 2019, 3-D Culture and Endothelial Cells Improve Maturity of Human Pluripotent Stem Cell-Derived Hepatocytes, Acta Biomater., 95, 371, 10.1016/j.actbio.2019.07.047 · DOI · Paper page
  6. Bacabac, 2005, Dynamic Shear Stress in Parallel-Plate Flow Chambers, J. Biomech., 38, 159, 10.1016/j.jbiomech.2004.03.020 · DOI · Paper page
  7. Baert, 2020, A Multi-Organ-Chip Co-culture of Liver and Testis Equivalents: a First Step toward a Systemic Male Reprotoxicity Model, Hum. Reprod., 35, 1029, 10.1093/humrep/deaa057 · DOI
  8. Bale, 2014, In Vitroplatforms for Evaluating Liver Toxicity, Exp. Biol. Med. (Maywood), 239, 1180, 10.1177/1535370214531872 · DOI · Paper page
  9. Berger, 2014, Enhancing the Functional Maturity of iPSC-Derived Human Hepatocytes via Controlled Presentation of Cell-Cell Interactions In Vitro, Hepatology, 61, 1370, 10.1002/hep.27621 · DOI · Paper page
  10. Bhushan, 2016, New Technologies in Drug Metabolism and Toxicity Screening: Organ-To-Organ Interaction, Expert Opin. Drug Metab. Toxicol., 12, 475, 10.1517/17425255.2016.1162292 · DOI
  11. Bircsak, 2021, A 3D Microfluidic Liver Model for High Throughput Compound Toxicity Screening in the OrganoPlate, Toxicology, 450, 152667, 10.1016/j.tox.2020.152667 · DOI · Paper page
  12. Boeri, 2019, Advanced Organ-On-A-Chip Devices to Investigate Liver Multi-Organ Communication: Focus on Gut, Microbiota Brain Bioeng. (Basel), 6, 10.3390/bioengineering6040091 · DOI
  13. Boggess, 2019, New Molecular Scaffolds for Fluorescent Voltage Indicators, ACS Chem. Biol., 14, 390, 10.1021/acschembio.8b00978 · DOI
  14. Bohets, 2000, Identification of the Cytochrome P450 Enzymes Involved in the Metabolism of Cisapride: In Vitro Studies of Potential Co-medication Interactions, Br. J. Pharmacol., 129, 1655, 10.1038/sj.bjp.0703246 · DOI
  15. Braet, 2002, Structural and Functional Aspects of Liver Sinusoidal Endothelial Cell Fenestrae: a Review, Comp. Hepatol., 1, 1, 10.1186/1476-5926-1-1 · DOI · Paper page
  16. Chakraborty, 2007, Multiscale Model for Pulmonary Oxygen Uptake and its Application to Quantify Hypoxemia in Hepatopulmonary Syndrome, J. Theor. Biol., 244, 190, 10.1016/j.jtbi.2006.07.030 · DOI
  17. Choi, 2011, Liver Engraftment Potential of Hepatic Cells Derived from Patient-specific Induced Pluripotent Stem Cells, Cell Cycle, 10, 2423, 10.4161/cc.10.15.16869 · DOI
  18. Comeau, 2007, Cisapride Class-Action Suit Approved, Can. Med. Assoc. J., 176, 615, 10.1503/cmaj.070156 · doi:10.1503/cmaj.070156
  19. Craveiro, 2020, Drug Withdrawal Due to Safety: A Review of the Data Supporting Withdrawal Decision, Cds, 15, 4, 10.2174/1574886314666191004092520 · DOI
  20. Crumb, 2016, An Evaluation of 30 Clinical Drugs against the Comprehensive In Vitro Proarrhythmia Assay (CiPA) Proposed Ion Channel Panel, J. Pharmacol. Toxicol. Methods, 81, 251, 10.1016/j.vascn.2016.03.009 · DOI · Paper page
  21. Dalgetty, 2009, Progress and Future Challenges in Stem Cell-Derived Liver Technologies, Am. J. Physiology-Gastrointestinal Liver Physiol., 297, G241, 10.1152/ajpgi.00138.2009 · DOI · Paper page
  22. Dash, 2009, Liver Tissue Engineering in the Evaluation of Drug Safety, Expert Opin. Drug Metab. Toxicol., 5, 1159, 10.1517/17425250903160664 · DOI · Paper page
  23. Dittrich, 2006, Lab-on-a-chip: Microfluidics in Drug Discovery, Nat. Rev. Drug Discov., 5, 210, 10.1038/nrd1985 · DOI · Paper page
  24. Dunn, 1991, Long-term In Vitro Function of Adult Hepatocytes in a Collagen Sandwich Configuration, Biotechnol. Prog., 7, 237, 10.1021/bp00009a007 · DOI · Paper page
  25. Ebrahimkhani, 2014, Bioreactor Technologies to Support Liver Function In Vitro, Adv. Drug Deliv. Rev., 132, 10.1016/j.addr.2014.02.011 · DOI · Paper page
  26. Ewer, 2015, Cardiotoxicity of Anticancer Treatments, Nat. Rev. Cardiol., 12, 547, 10.1038/nrcardio.2015.65 · DOI · Paper page
  27. Fridericia, 1920, Die Systolendauer im Elektrokardiogramm bei normalen Menschen und bei Herzkranken, Acta Med. Scand., 53, 469, 10.1111/j.0954-6820.1920.tb18266.x · DOI · Paper page
  28. Fridericia, 2003, The Duration of Systole in an Electrocardiogram in Normal Humans and in Patients with Heart Disease*, Ann. Noninvasive Electrocardiol., 8, 343, 10.1046/j.1542-474x.2003.08413.x · DOI · Paper page
  29. Gieseck, 2014, Maturation of Induced Pluripotent Stem Cell Derived Hepatocytes by 3D-Culture, PLoS ONE, 9, e86372, 10.1371/journal.pone.0086372 · DOI · Paper page
  30. Griffith, 2014, Engineering Liver, Hepatology, 60, 1426, 10.1002/hep.27150 · DOI · Paper page
  31. Guo, 2011, Estimating the Risk of Drug-Induced Proarrhythmia Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Toxicol. Sci., 123, 281, 10.1093/toxsci/kfr158 · DOI · Paper page
  32. Hannan, 2013, Production of Hepatocyte-like Cells from Human Pluripotent Stem Cells, Nat. Protoc., 8, 430, 10.1038/nprot.2012.153 · DOI · Paper page
  33. Haraguchi, 2015, Electrophysiological Analysis of Mammalian Cells Expressing hERG Using Automated 384-Well-Patch-Clamp, BMC Pharmacol. Toxicol., 16, 16, 10.1186/s40360-015-0042-9 · doi:10.1186/s40360-015-0042-9
  34. Harris, 2013, Comparison of Electrophysiological Data from Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes to Functional Preclinical Safety Assays, Toxicol. Sci., 134, 412, 10.1093/toxsci/kft113 · DOI · Paper page
  35. Herper, 2013, The Cost of Creating a New Drug Now $5 Billion, Pushing Big Pharma to Change
  36. Hondeghem, 2001, Instability and Triangulation of the Action Potential Predict Serious Proarrhythmia, but Action Potential Duration Prolongation Is Antiarrhythmic, Circulation, 103, 2004, 10.1161/01.cir.103.15.2004 · DOI · Paper page
  37. Hondeghem, 2008, Use and Abuse of QT and TRIaD in Cardiac Safety Research: Importance of Study Design and Conduct, Eur. J. Pharmacol., 584, 1, 10.1016/j.ejphar.2008.01.016 · DOI
  38. Horn, 1987, Alcoholic Liver Injury: Defenestration in Noncirrhotic Livers-A Scanning Electron Microscopic Study, Hepatology, 7, 77, 10.1002/hep.1840070117 · DOI · Paper page
  39. Huang, 2015, A Photostable Silicon Rhodamine Platform for Optical Voltage Sensing, J. Am. Chem. Soc., 137, 10767, 10.1021/jacs.5b06644 · DOI · Paper page
  40. Huebsch, 2018, Metabolically-Driven Maturation of hiPSC-Cell Derived Heart-On-A-Chip, bioRxiv, 485169, 10.1101/485169 · DOI
  41. Huebsch, 2015, Automated Video-Based Analysis of Contractility and Calcium Flux in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Cultured over Different Spatial Scales, Tissue Eng. C: Methods, 21, 467, 10.1089/ten.tec.2014.0283 · DOI · Paper page
  42. Hyland, 2003, Identification of the Cytochrome P450 Enzymes Involved in theN-Oxidation of Voriconazole, Drug Metab. Dispos, 31, 540, 10.1124/dmd.31.5.540 · DOI · Paper page
  43. Inamdar, 2011, Microfluidic Cell Culture Models for Tissue Engineering, Curr. Opin. Biotechnol., 22, 681, 10.1016/j.copbio.2011.05.512 · DOI · Paper page
  44. Inamdar, 2011, Transport and Shear in a Microfluidic Membrane Bilayer Device for Cell Culture, Biomicrofluidics, 5, 022213, 10.1063/1.3576925 · DOI
  45. Jæger, 2019, Improved Computational Identification of Drug Response Using Optical Measurements of Human Stem Cell Derived Cardiomyocytes in Microphysiological Systems, Front. Pharmacol., 10, 1648, 10.3389/fphar.2019.01648 · DOI
  46. Jianling, 2009, Recent Advances in Physicochemical and ADMET Profiling in Drug Discovery, Chem. Biodiversity, 6, 1887, 10.1002/cbdv.200900117 · DOI
  47. Kim, 2013, Mathematical Analysis of Oxygen Transfer through Polydimethylsiloxane Membrane between Double Layers of Cell Culture Channel and Gas Chamber in Microfluidic Oxygenator, Microfluid Nanofluid, 15, 285, 10.1007/s10404-013-1142-8 · DOI · Paper page
  48. Kyungsuk, 2014, Physiologically Relevant Organs on Chips, Biotechnol. J., 9, 16, 10.1002/biot.201300187 · DOI · Paper page
  49. Laughner, 2012, Processing and Analysis of Cardiac Optical Mapping Data Obtained with Potentiometric Dyes, Am. J. Physiology-Heart Circulatory Physiol., 303, H753, 10.1152/ajpheart.00404.2012 · DOI · Paper page
  50. Lee, 2018, Gut-liver on a Chip toward an In Vitro Model of Hepatic Steatosis, Biotechnol. Bioeng., 115, 2817, 10.1002/bit.26793 · DOI · Paper page
  51. Lee-Montiel, 2017, Control of Oxygen Tension Recapitulates Zone-specific Functions in Human Liver Microphysiology Systems, Exp. Biol. Med. (Maywood), 242, 1617, 10.1177/1535370217703978 · DOI · Paper page
  52. Liang, 2013, Drug Screening Using a Library of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveals Disease-specific Patterns of Cardiotoxicity, Circulation, 127, 1677, 10.1161/circulationaha.113.001883 · DOI · Paper page
  53. Liu, 2011, In Vivo Liver Regeneration Potential of Human Induced Pluripotent Stem Cells from Diverse Origins, Sci. Translational Med., 3, 82ra39, 10.1126/scitranslmed.3002376 · DOI · Paper page
  54. Liu, 2010, Generation of Endoderm-Derived Human Induced Pluripotent Stem Cells from Primary Hepatocytes, Hepatology, 51, 1810, 10.1002/hep.23626 · DOI · Paper page
  55. Liu, 2006, Blinded Validation of the Isolated Arterially Perfused Rabbit Ventricular Wedge in Preclinical Assessment of Drug-Induced Proarrhythmias, Heart Rhythm, 3, 948, 10.1016/j.hrthm.2006.04.021 · DOI
  56. Loskill, 2017, WAT-on-a-chip: a Physiologically Relevant Microfluidic System Incorporating White Adipose Tissue, Lab. Chip, 17, 1645, 10.1039/c6lc01590e · DOI · Paper page
  57. Marconi, 2014, Postnatal Hyperoxia Exposure Differentially Affects Hepatocytes and Liver Haemopoietic Cells in Newborn Rats, PLoS One, 9, e105005, 10.1371/journal.pone.0105005 · DOI
  58. Markov, 2014, Variation in Diffusion of Gases through PDMS Due to Plasma Surface Treatment and Storage Conditions, Biomed. Microdevices, 16, 91, 10.1007/s10544-013-9808-2 · DOI · Paper page
  59. Mathur, 2013, Human Induced Pluripotent Stem Cell-Based Microphysiological Tissue Models of Myocardium and Liver for Drug Development, Stem Cel Res. Ther., 4, S14, 10.1186/scrt375 · DOI · Paper page
  60. Mathur, 2015, Human iPSC-Based Cardiac Microphysiological System for Drug Screening Applications, Scientific Rep., 5, 8883, 10.1038/srep08883 · DOI · Paper page
  61. McAleer, 2019, On the Potential of In Vitro Organ-Chip Models to Define Temporal Pharmacokinetic-Pharmacodynamic Relationships, Sci. Rep., 9, 9619, 10.1038/s41598-019-45656-4 · DOI · Paper page
  62. Meuldermans, 1988, Excretion and Biotransformation of Cisapride in Dogs and Humans after Oral Administration, Drug Metab. Dispos, 16, 403
  63. Mi, 2013, Efficient Drug Screening and Gene Correction for Treating Liver Disease Using Patient‐specific Stem Cells, Hepatology, 57, 2458, 10.1002/hep.26237 · DOI · Paper page
  64. Michalets, 2000, Drug Interactions with Cisapride, Clin. Pharmacokinet., 39, 49, 10.2165/00003088-200039010-00004 · DOI
  65. Mishra, 2009, Real Time In Vitro Measurement of Oxygen Uptake Rates for HEPG2 Liver Cells Encapsulated in Alginate Matrices, Microfluid Nanofluid, 6, 373, 10.1007/s10404-008-0396-z · DOI
  66. Moradi, 2020, Microfluidic Organ-On-A-Chip Models of Human Liver Tissue, Acta Biomater., 116, 67, 10.1016/j.actbio.2020.08.041 · DOI · Paper page
  67. Mun, 2019, Generation of Expandable Human Pluripotent Stem Cell-Derived Hepatocyte-like Liver Organoids, J. Hepatol., 71, 970, 10.1016/j.jhep.2019.06.030 · DOI · Paper page
  68. Nahmias, 2006, Endothelium-Mediated Hepatocyte Recruitment in the Establishment of Liver-like TissueIn Vitro, Tissue Eng., 12, 1627, 10.1089/ten.2006.12.1627 · DOI · Paper page
  69. Okada, 2015, Screening System for Drug-Induced Arrhythmogenic Risk Combining a Patch Clamp and Heart Simulator, Sci. Adv., 1, 2375, 10.1126/sciadv.1400142 · DOI · Paper page
  70. Oleaga, 2018, Investigation of the Effect of Hepatic Metabolism on Off-Target Cardiotoxicity in a Multi-Organ Human-On-A-Chip System, Biomaterials, 182, 176, 10.1016/j.biomaterials.2018.07.062 · DOI · Paper page
  71. Paakkari, 2002, Cardiotoxicity of New Antihistamines and Cisapride, Toxicol. Lett., 127, 279, 10.1016/s0378-4274(01)00510-0 · DOI
  72. Park, 2005, Microfabricated Grooved Substrates as Platforms for Bioartificial Liver Reactors, Biotechnol. Bioeng., 90, 632, 10.1002/bit.20463 · DOI · Paper page
  73. Park, 2008, Radial Flow Hepatocyte Bioreactor Using Stacked Microfabricated Grooved Substrates, Biotechnol. Bioeng., 99, 455, 10.1002/bit.21572 · DOI · Paper page
  74. Pearce, 2001, Cytochrome P450 Involvement in the Biotransformation of Cisapride and Racemic Norcisapride In Vitro: Differential Activity of Individual Human CYP3A Isoforms, Drug Metab. Dispos, 29, 1548
  75. Pires de Mello, 2020, Microphysiological Heart-Liver Body-On-A-Chip System with a Skin Mimic for Evaluating Topical Drug Delivery, Lab. Chip, 20, 749, 10.1039/c9lc00861f · DOI
  76. Provin, 2009, Low O2 Metabolism of HepG2 Cells Cultured at High Density in a 3D Microstructured Scaffold, Biomed. Microdevices, 11, 485, 10.1007/s10544-008-9254-8 · DOI
  77. Redfern, 2003, Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development, Cardiovasc. Res., 58, 32, 10.1016/s0008-6363(02)00846-5 · DOI · Paper page
  78. Schepers, 2016, Engineering a Perfusable 3D Human Liver Platform from iPS Cells, Lab. Chip, 16, 2644, 10.1039/c6lc00598e · DOI · Paper page
  79. Scott, 2013, Human Induced Pluripotent Stem Cells and Their Use in Drug Discovery for Toxicity Testing, Toxicol. Lett., 219, 49, 10.1016/j.toxlet.2013.02.020 · DOI
  80. Shah, 2002, The Significance of QT Interval in Drug Development, Br. J. Clin. Pharmacol., 54, 188, 10.1046/j.1365-2125.2002.01627.x · DOI · Paper page
  81. Shimada, 1996, Characterization of Microsomal Cytochrome P450 Enzymes Involved in the Oxidation of Xenobiotic Chemicals in Human Fetal Liver and Adult Lungs, Drug Metab. Dispos, 24, 515
  82. Shirure, 2017, Design Considerations to Minimize the Impact of Drug Absorption in Polymer-Based Organ-On-A-Chip Platforms, Lab. Chip, 17, 681, 10.1039/c6lc01401a · DOI · Paper page
  83. Sip, 2014, Stable Chemical Bonding of Porous Membranes and Poly (Dimethylsiloxane) Devices for Long-Term Cell Culture, Biomicrofluidics, 8, 036504, 10.1063/1.4883075 · DOI
  84. Soldatow, 2013, In vitro models for Liver Toxicity Testing, Toxicol. Res., 2, 23, 10.1039/c2tx20051a · DOI · Paper page
  85. Song, 2009, Efficient Generation of Hepatocyte-like Cells from Human Induced Pluripotent Stem Cells, Cell Res, 19, 1233, 10.1038/cr.2009.107 · DOI · Paper page
  86. Sung, 2010, In vitro microscale Systems for Systematic Drug Toxicity Study, Bioproc. Biosyst Eng, 33, 5, 10.1007/s00449-009-0369-y · DOI
  87. Takahashi, 2007, Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors, Cell, 131, 10.1016/j.cell.2007.11.019 · DOI · Paper page
  88. Takahashi, 2006, Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 · DOI · Paper page
  89. Tilles, 2001, Effects of Oxygenation and Flow on the Viability and Function of Rat Hepatocytes Cocultured in a Microchannel Flat-Plate Bioreactor, Biotechnol. Bioeng., 73, 379, 10.1002/bit.1071 · DOI · Paper page
  90. Tréluyer, 2001, Evidence of Impaired Cisapride Metabolism in Neonates, Br. J. Clin. Pharmacol., 52, 419, 10.1046/j.0306-5251.2001.01470.x · DOI
  91. Tuschl, 2009, Serum-free Collagen Sandwich Cultures of Adult Rat Hepatocytes Maintain Liver-like Properties Long Term: A Valuable Model for In Vitro Toxicity and Drug-Drug Interaction Studies, Chemico-Biological Interactions, 181, 124, 10.1016/j.cbi.2009.05.015 · DOI
  92. Tveito, 2018, Inversion and Computational Maturation of Drug Response Using Human Stem Cell Derived Cardiomyocytes in Microphysiological Systems, Sci. Rep., 8, 17626, 10.1038/s41598-018-35858-7 · DOI
  93. Vinci, 2011, Modular Bioreactor for Primary Human Hepatocyte Culture: Medium Flow Stimulates Expression and Activity of Detoxification Genes, Biotechnol. J., 6, 554, 10.1002/biot.201000326 · DOI · Paper page
  94. Vollmar, 2009, The Hepatic Microcirculation: Mechanistic Contributions and Therapeutic Targets in Liver Injury and Repair, Physiol. Rev., 89, 1269, 10.1152/physrev.00027.2008 · DOI · Paper page
  95. Wiseman, 1994, Cisapride, Drugs, 47, 116, 10.2165/00003495-199447010-00008 · DOI · Paper page
  96. Wysowski, 1996, Cisapride and Fatal Arrhythmia, N. Engl. J. Med., 335, 290, 10.1056/nejm199607253350416 · DOI · Paper page
  97. Wysowski, 2001, Postmarketing Reports of QT Prolongation and Ventricular Arrhythmia in Association with Cisapride and Food and Drug Administration Regulatory Actions, Am. J. Gastroenterol., 96, 1698, 10.1111/j.1572-0241.2001.03927.x · doi:10.1111/j.1572-0241.2001.03927.x · Paper page
  98. Zhu, 2014, Mouse Liver Repopulation with Hepatocytes Generated from Human Fibroblasts, Nature, 508, 93, 10.1038/nature13020 · DOI · Paper page

Cited by

See all 54

Metadata

Authors
Lee-Montiel, F. T., Laemmle, A., Charwat, V., Dumont, L., Lee, C. S., Huebsch, N., Okochi, H., Hancock, M. J., Siemons, B., Boggess, S. C., Goswami, I., Miller, E. W., Willenbring, H., & Healy, K. E.
Venue
Frontiers in Pharmacology
Published
2021-05-07
Volume
12
Pages
667010-667010
ISSN
1663-9812 (ISSN-L)
OpenAlex
W3157067478
Cited by
54
References
25
FWCI
2.52
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Integrated Isogenic Human Induced Pluripotent Stem Cell–Based Liver and Heart Microphysiological Systems Predict Unsafe Drug–Drug Interaction. https://app.cochat.ai/papers/10.3389/fphar.2021.667010
The paper
Lee-Montiel, F. T., Laemmle, A., Charwat, V., Dumont, L., Lee, C. S., Huebsch, N., Okochi, H., Hancock, M. J., Siemons, B., Boggess, S. C., Goswami, I., Miller, E. W., Willenbring, H., & Healy, K. E. (2021). Integrated Isogenic Human Induced Pluripotent Stem Cell–Based Liver and Heart Microphysiological Systems Predict Unsafe Drug–Drug Interaction. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2021.667010

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.